<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02233582</url>
  </required_header>
  <id_info>
    <org_study_id>Ibuprofen and Altitude</org_study_id>
    <nct_id>NCT02233582</nct_id>
  </id_info>
  <brief_title>Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDS) on Acclimatization to High Altitude</brief_title>
  <official_title>Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDS) on Acclimatization to High Altitude</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ibuprofen is often taken by travelers to high altitude to treat the symptoms of acute
      mountain sickness such as headache and malaise. However, the blunting of inflammation by
      ibuprofen may slow the process of acclimatization to altitude, which relies on mediators of
      inflammation for adjustments in breathing.

      The study randomizes healthy subjects to receive ibuprofen or placebo and then ascend to
      altitude (12,500 feet). Blood cytokines and non-invasive measurements of blood and tissue
      oxygen levels will be made for 48 hours at altitude. The hypothesis being tested is that
      subjects receiving ibuprofen will have lower blood and tissue oxygen levels after 48 hours at
      altitude than will placebo subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will begin with 2 days of studies in San Francisco (sea level baseline).
      Measurements will include non-invasive measurements of blood and tissue oxygen and venous
      blood draws for cytokine levels.

      The altitude part of the study involves ascent to the University of California's White
      Mountain Research Center Barcroft Laboratory, at 12,500 feet elevation. The subjects will
      remain at that altitude for at least 48 hours for measurements of oxygenation and blood
      cytokines.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">October 2015</completion_date>
  <primary_completion_date type="Anticipated">October 2015</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>blood cytokine levels</measure>
    <time_frame>on days 1 and 2 at sea level, on arrival at altitude and daily for 2 days</time_frame>
    <description>venous blood sample, once a day</description>
  </primary_outcome>
  <primary_outcome>
    <measure>cerebral blood flow</measure>
    <time_frame>once daily for 2 days at sea level, on arrival at altitude and once daily at altitude for 2 days</time_frame>
    <description>optical/non-invasive measure of frontal cortex cerebral blood flow with an FDA-approved device</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pulse oximetry</measure>
    <time_frame>once a day for 2 days at sea level, on arrival at altitude and daily for 2 days</time_frame>
    <description>finger pulse oximetry with an FDA approved pulse oximeter</description>
  </secondary_outcome>
  <other_outcome>
    <measure>cerebral oximetry</measure>
    <time_frame>once daily for 2 days at sea level, on arrival at altitude and daily for 2 days</time_frame>
    <description>non-invasive measurements of cerebral oxygenation with an FDA approved device</description>
  </other_outcome>
  <other_outcome>
    <measure>acute mountain sickness inventory</measure>
    <time_frame>once a day at both sea level (2 days) and altitude (2 days)</time_frame>
    <description>standard questionnaire concerning symptoms associated with acute mountain sickness</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>High Altitude</condition>
  <arm_group>
    <arm_group_label>ibuprofen plus ascent to high altitude</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subjects randomized to this arm will take ibuprofen 200 mg 3 times daily during ascent and at altitude.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sugar pill plus ascent to high altitude</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>subjects randomized to this arm will receive the placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen</intervention_name>
    <description>We are simply testing if taking ibuprofen upon ascent to altitude is associated with a delayed acclimatization response to the high altitude hypoxia.</description>
    <arm_group_label>ibuprofen plus ascent to high altitude</arm_group_label>
    <other_name>motrin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy subjects

        Exclusion Criteria:

          -  pregnancy

          -  contraindication to taking ibuprofen
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>White Mountain Research Center</name>
      <address>
        <city>Bishop</city>
        <state>California</state>
        <zip>95740</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Philip Bickler, MD, PhD</last_name>
      <phone>415-476-1411</phone>
      <email>bicklerp@anesthesia.ucsf.edu</email>
    </contact>
    <contact_backup>
      <last_name>John Feiner</last_name>
      <phone>4154768624</phone>
      <email>feinerj@anesthesia.ucsf.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Philip Bickler, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UCSF Hypoxia Research Laboratory</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paul Au, BS</last_name>
      <phone>415-476-1412</phone>
      <email>aupaul@anesthesia.ucsf.edu</email>
    </contact>
    <contact_backup>
      <last_name>Philip Bickler, MD, PHD</last_name>
      <phone>4154761411</phone>
    </contact_backup>
    <investigator>
      <last_name>Philip Bickler, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 3, 2014</study_first_submitted>
  <study_first_submitted_qc>September 3, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2014</study_first_posted>
  <last_update_submitted>September 9, 2014</last_update_submitted>
  <last_update_submitted_qc>September 9, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 10, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>altitude</keyword>
  <keyword>mountain sickness</keyword>
  <keyword>ibuprofen</keyword>
  <keyword>hypoxia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Altitude Sickness</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Anti-Inflammatory Agents, Non-Steroidal</mesh_term>
    <mesh_term>Anti-Inflammatory Agents</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>October 24, 2017</submitted>
    <submission_canceled>Unknown</submission_canceled>
    <submitted>January 25, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

